References
-
1) Maf1 mitigates sevoflurane-induced microglial inflammatory damage and attenuates microglia-mediated neurotoxicity in HT-22 cells by activating the AMPK/Nrf2 signaling.
Year: 2022Journal: NEUROTOXICOLOGYImpactFactor: 3.4DOI: 10.1016/j.neuro.2022.04.003PMID: 35430185 -
2) Increased S. Aureus Colonization and Reduced Antimicrobial Peptide Expression in Erythrodermic Psoriasis.
Product: Ribonuclease 7 Antibody (#DF14437)Year: 2024Journal: Int ImmunopharmacolImpactFactor: 5.6DOI: 10.1016/j.intimp.2023.111343PMID: 38096593 -
3) Alleviated NCOA4-mediated ferritinophagy protected RA FLSs from ferroptosis in lipopolysaccharide-induced inflammation under hypoxia.
Product: IREB2 Antibody (#DF14436)Year: 2024Journal: Inflamm ResImpactFactor: 6.7DOI: 10.1007/s00011-023-01842-9PMID: 38189810 -
4) Single‐cell and spatial analyses reveal the association between gene expression of glutamine synthetase with the immunosuppressive phenotype of APOE+CTSZ+TAM in cancers.
Product: Cathepsin Z Antibody (#DF14386)Year: 2023Journal: MOL ONCOLImpactFactor: 6.6DOI: 10.1002/1878-0261.13373PMID: 36587392 -
5) Comprehensive analysis identifies CLEC1B as a potential prognostic biomarker in hepatocellular carcinoma.
Product: CLEC1B Antibody (#DF14376)Year: 2023Journal: Cancer Cell IntImpactFactor: 5.8DOI: 10.1186/s12935-023-02939-1PMID: 37308868 -
6) TP53INP2 knockdown inhibits inflammatory response and apoptosis after spinal cord injury.
Product: TP53INP2 Antibody (#DF14312)Year: 2024Journal: Immun Inflamm DisImpactFactor: 3.2DOI: 10.1002/iid3.1256PMID: 38652010 -
7) Proteomic insights into the regulatory function of ARID1A in colon cancer cells.
Product: ZNRF3 Antibody (#DF14289)Year: 2024Journal: Oncol LettImpactFactor: 2.9DOI: 10.3892/ol.2024.14525PMID: 38966585 -
8) Self-Assembled Immunostimulatory Nanodrug Combined with PD-L1 for Boosting Anti-Tumor Chemoimmunotherapy.
-
9) Multistage Cooperative Nanodrug Combined with PD‐L1 for Enhancing Antitumor Chemoimmunotherapy.
Product: DNase I Antibody (#DF14243)Year: 2021Journal: ADV HEALTHC MATERImpactFactor: 10DOI: 10.1002/adhm.202101199PMID: 34382363 -
10) SLC39A14 may be a characteristic gene affecting the development of Barrett's esophagus.
Product: SLC39A14 Antibody (#DF14224)Year: 2023Journal: Research SquareDOI: 10.21203/rs.3.rs-3224247/v1 -
11) Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma.
Product: SLC39A14 Antibody (#DF14224)Year: 2023Journal: J CANCERImpactFactor: 3.9DOI: 10.7150/jca.68568PMID: 35371305 -
12) Lycium barbarum polysaccharide remodels colon inflammatory microenvironment and improves gut health.
Product: GPCR TGR5 Antibody (#DF14067)Year: 2024Journal: HeliyonImpactFactor: 4DOI: 10.1016/j.heliyon.2024.e30594PMID: 38774318 -
13) Low–Molecular Weight Fucoidan Polysaccharide Inhibits Pulmonary Fibrosis by Regulating M1/M2 Macrophages Polarization.
Product: RELM beta Antibody (#DF13943)Year: 2022Journal: Research SquareDOI: 10.21203/rs.3.rs-1875874/v1 -
14) ONECUT2 which is targeted by hsa-miR-15a-5p enhances stemness maintenance of gastric cancer stem cells.
Product: ONECUT2 Antibody (#DF13779)Year: 2021Journal: EXP BIOL MEDImpactFactor: 3.2DOI: 10.1177/15353702211038496PMID: 34365839 -
15) Traditional Chinese Medicine Shi-Bi-Man ameliorates psoriasis via inhibiting IL-23/Th17 axis and CXCL16-mediated endothelial activation.
Product: IL23 Antibody (#DF13760)Year: 2024Journal: Chin MedImpactFactor: 4.9DOI: 10.1186/s13020-024-00907-zPMID: 38429819